Friday’s Rally Put Markets at Critical Juncture

Friday’s Rally Put Markets at Critical Juncture

Markets are on the cusp of a breakout after Friday’s rally. Will the momentum hold, or is turbulence ahead?


The Perfect Time to Buy Crypto

The Perfect Time to Buy Crypto

Robert uses this odd tool to know when to buy crypto… and it says it’s time to buy.


<em>Dealmaker’s Diary</em>: A Massive AI Stock Opportunity

Dealmaker’s Diary: A Massive AI Stock Opportunity

AMD has dropped 50%, but history suggests a major rebound. Here’s why this AI stock could double in the next 1-2 years.


<em>Buy This, Not That</em>: Which Stock Wins The Home Improvement Showdown

Buy This, Not That: Which Stock Wins The Home Improvement Showdown

Home Depot and Lowe’s both popped on earnings, but one chart reveals why only one deserves your investment dollars right now.


This Biotech Has a Tech Company’s DNA

This Biotech Has a Tech Company’s DNA

Most biotechs burn cash, but this one’s turning heads with its 34.8x return on invested capital and PE ratio of 18.6x – well below industry average.


<em>Buy This, Not That</em>: Intel’s Pain Is This Stock’s Gain

Buy This, Not That: Intel’s Pain Is This Stock’s Gain

As semiconductor giants circle Intel’s assets, one emerges as the clear winner for investors – but it’s not the obvious choice.


<em>Dealmaker’s Diary</em>: Why This $1.5B Stock Buyback Matters

Dealmaker’s Diary: Why This $1.5B Stock Buyback Matters

Beyond the headlines about a major hedge fund stake, this tech giant’s metrics suggest significant upside ahead.


<em>Buy This, Not That</em>: Super Bowl’s Big Winners (It’s Not Who You Think)

Buy This, Not That: Super Bowl’s Big Winners (It’s Not Who You Think)

The real competition wasn’t on the field – it was during commercial breaks. Here’s what these epic ads tell us about two major stocks.


Market Check: Why I’m Not Worried (Yet)

Market Check: Why I’m Not Worried (Yet)

Markets remain inches from record highs despite recent weakness. While the Magnificent Seven show concerning divergence, we haven’t seen a 5% correction since fall.


<em>Dealmaker’s Diary</em>: Don’t Let This Common Metric Cost You Money

Dealmaker’s Diary: Don’t Let This Common Metric Cost You Money

Traditional valuation metrics can mislead investors. Here’s how to look beyond simple ratios for better returns.


BROUGHT TO YOU BY MANWARD PRESS